File #: 26-0109    Version: 1
Type: City Resolution Status: In Committee
File created: 9/24/2025 In control: * Concurrent Meeting of the Oakland Redevelopment Successor Agency and the City Council
On agenda: 10/7/2025 Final action:
Title: Subject: National Prescription Opiate Litigation From: Office Of The City Attorney Recommendation: Adopt A Resolution Authorizing The City Attorney To: (1) Release The City's Potential Claims As Necessary To Join Eight National Settlement Agreements With Opioid Manufacturers Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, And Zydus, And The Accompanying California State-Subdivision Agreements; And (2) Release The City's Claims Against Purdue Pharma And Sackler Entities As Necessary To Consent And Participate In The Accompanying Bankruptcy Plan And Settlement Agreements (Office Of The City Attorney - Public Nuisance, False Advertising, Unfair Competition)
Sponsors: Office Of The City Attorney
Attachments: 1. View Report, 2. View Legislation

Title

Subject:                      National Prescription Opiate Litigation

From:                                           Office Of The City Attorney

Recommendation: Adopt A Resolution Authorizing The City Attorney To: (1) Release The City’s Potential Claims As Necessary To Join Eight National Settlement Agreements With Opioid Manufacturers Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, And Zydus, And The Accompanying California State-Subdivision Agreements; And (2) Release The City’s Claims Against Purdue Pharma And Sackler Entities As Necessary To Consent And Participate In The Accompanying Bankruptcy Plan And Settlement Agreements (Office Of The City Attorney - Public Nuisance, False Advertising, Unfair Competition)